These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2945695)

  • 1. Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.
    Holers VM; Seya T; Brown E; O'Shea JJ; Atkinson JP
    Complement; 1986; 3(2):63-78. PubMed ID: 2945695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid purification of the human C3b/C4b receptor (CR1) by monoclonal antibody affinity chromatography.
    Wong WW; Jack RM; Smith JA; Kennedy CA; Fearon DT
    J Immunol Methods; 1985 Oct; 82(2):303-13. PubMed ID: 2931485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus regulates activation and processing of the third component of complement.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD; Lambris JD
    J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T; Lavoie S; Nussenzweig V
    J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping.
    Nickells MW; Seya T; Holers VM; Atkinson JP
    Mol Immunol; 1986 Jun; 23(6):661-8. PubMed ID: 2943987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.
    Jepsen HH; Teisner B; Svehag SE
    Scand J Immunol; 1990 Apr; 31(4):397-403. PubMed ID: 2139734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
    Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
    J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells.
    Kinoshita T; Medof ME; Hong K; Nussenzweig V
    J Exp Med; 1986 Nov; 164(5):1377-88. PubMed ID: 2430040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CR1- and membrane cofactor protein-like proteins of two primates.
    Nickells MW; Atkinson JP
    J Immunol; 1990 Jun; 144(11):4262-8. PubMed ID: 2140391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular CR1 express in situ cofactor activity for degradation of C3b.
    Vedeler CA; Matre R; Iversen BM
    Int Arch Allergy Appl Immunol; 1990; 92(1):60-3. PubMed ID: 2147176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.